Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction, a sub-study of DAPA-VO2.

20 May 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Miss Martina Amiguet Comins

General University Hospital of Castellon, Castellon de la Plana (Spain)

7 More presentations in this session

Presentation thumbnail

Altered myokine profile and glycemic control in type 2 diabetes mellitus patients with heart failure

Professor A. Berezin (Salzburg, AT)

Abstract Slides

Presentation thumbnail

Endothelial dysfunction represented by the endothelial activation and stress index (EASIX) is associated with lower overall survival in chronic heart failure patients

Mr B. Estler (Heidelberg, DE)

Abstract Slides

Presentation thumbnail

NT-pro-BNP as only biomarker for the monitoring of cardiac amyloidosis patients

Miss J. Krief (Montpellier, FR)

Abstract Slides

Presentation thumbnail

Secretoneurin is produced and released from the myocardium of patients with Takotsubo syndrome

Professor H. Rosjo (Nordbyhagen, NO)

Abstract Slides

Presentation thumbnail

Vascular endothelial growth factor C as a potential biomarker of peripheral tissue congestion in acute heart failure.

Mr G. Iwanek (Wroclaw, PL)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart Failure - biomarkers 2

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Presentation

Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources